Carbamazepine (CBZ) has been reported to have an antidiuretic action, though it is not known how it produces this effect. This is a well recognized complication of CBZ therapy in adults. However this syndrome has been rarely observed in childhood. We present an epileptic child with fluid overload due to CBZ treatment who was referred with chest pain and cardiomegaly. Our patient developed fluid retention with cardiomegaly during treatment with CBZ alone at a normal dose and for a short time. To our knowledge this is the first case of the syndrome of inappropriate antidiuretic hormone secretion (SIADH) due to CBZ therapy which has been observed to be associated with cardiomegaly. (Jpn Heart J 34: 239-243, 1993.) Key Words: Carbamazepine therapy SIADH and cardiomegaly ARBAMAZEPINE has been used as an anticonvulsant since 1962. Various side effects such as drowsiness, dry mouth, nausea, vomiting, generalized erythema, photosensitivity, cardiac conduction disturbance and systemic lupus erythematosus have been documented.1)-3) In addition to these side effects, hyponatremia and low plasma osmolality have been reported in In this report, we present an epileptic child who developed fluid overload while receiving CBZ treatment. To our knowledge, this is the first case of the syndrome of inappropriate antidiuretic hormone secretion due to CBZ therapy which has been observed to be associated with cardiomegaly.
ARBAMAZEPINE has been used as an anticonvulsant since 1962. Various side effects such as drowsiness, dry mouth, nausea, vomiting, generalized erythema, photosensitivity, cardiac conduction disturbance and systemic lupus erythematosus have been documented.1)-3) In addition to these side effects, hyponatremia and low plasma osmolality have been reported in CBZ-treated patients. 4) In this report, we present an epileptic child who developed fluid overload while receiving CBZ treatment. To our knowledge, this is the first case of the syndrome of inappropriate antidiuretic hormone secretion due to CBZ therapy which has been observed to be associated with cardiomegaly. osmolality are shown in Table I . CBZ was tapered rather more rapidly than the classic method and then discontinued. Furosemide 2mg/kg was given for 5 days. The plasma and urine sodium concentrations returned to normal ranges within 3 days. Four days later, his weight was 60.2kg, central venous pressure was 11.5cmH2O and blood pressure was 120/75mmHg. After tapering CBZ, the cardiac findings disappeared completely and returned to normal within 7 days (Fig. 2) 
